Patents by Inventor Yasushi Fujitani

Yasushi Fujitani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160250238
    Abstract: The present invention provides a method for the prophylaxis or treatment of systemic lupus erythematosus and/or lupus nephritis in a patient in need thereof, which comprises administering an effective amount of [(1R)-1-({[(2, 5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl] boronic acid or a citric acid ester thereof, or a pharmaceutically acceptable salt thereof to the patient.
    Type: Application
    Filed: October 2, 2014
    Publication date: September 1, 2016
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: Toru Kawamura, Yasushi Fujitani, Masayuki Takizawa
  • Publication number: 20080131370
    Abstract: The present invention provides a method for screening for a prophylactic or therapeutic drug for apoptosis or an inflammation-associated disease, diabetes and complications thereof or a chronic obstructive pulmonary disease (COPD), namely, a method for screening for a prophylactic or therapeutic drug for apoptosis or an inflammation-associated disease, diabetes and complications thereof or COPD, which includes (1) comparing the activities of a protein having an amino acid sequence the same as or substantially the same as the amino acid sequence shown by SEQ ID NO: 2 or a partial peptide thereof or a salt thereof, between in the presence of a test substance and in the absence of the test substance, or (2) comparing the expressions of a protein having an amino acid sequence the same as or substantially the same as the amino acid sequence shown by SEQ ID NO: 2, a partial peptide thereof and a salt thereof in the cells having the ability to produce the protein, the partial peptide thereof and the salt thereof, be
    Type: Application
    Filed: April 26, 2005
    Publication date: June 5, 2008
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Masatoshi Hazama, Yasushi Fujitani, Hidenori Ichijo
  • Patent number: 7202394
    Abstract: The present application provides a human gene over-expressing animal, which is a non-human animal carrying a human hematopoietic prostaglandin D2 synthase gene in its somatic cell chromosome and expressing a large amount of human prostaglandin D2 synthase, wherein the animal is one obtained through ontogenesis of a totipotency cell of a non-human animal or offspring of the obtained animal, and the totipotency cell is introduced with said synthase gene. The present application also provides a method of using the transgenic animal for testing in vivo activity of a candidate for anti-allergy medicines, sleep-controlling substances and candidates for anti-obesity.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: April 10, 2007
    Assignees: Japan Science and Technology Corporation, Osaka Bioscience Institute, Oriental Yeast Co., Ltd.
    Inventors: Yoshihiro Urade, Yasushi Fujitani, Hiroaki Kitayama, Naoki Hayashi
  • Patent number: D298247
    Type: Grant
    Filed: June 23, 1986
    Date of Patent: October 25, 1988
    Assignee: Hitachi, Ltd.
    Inventors: Hiroyuki Kogane, Yasushi Fujitani, Tsukasa Ariyoshi, Shigeki Gushiken, Toru Kiyota, Ryuichiro Tanaka
  • Patent number: D298323
    Type: Grant
    Filed: February 11, 1986
    Date of Patent: November 1, 1988
    Assignee: Hitachi, Ltd.
    Inventors: Tsukasa Ariyoshi, Shigeki Gushiken, Hiroyuki Kogane, Yasushi Fujitani, Toru Kiyota, Ryuichiro Tanaka